Overview
Lymphocytic interstitial pneumonitis (LIP) is a rare inflammatory lung disorder characterized by lymphocytic infiltration of the interstitium, often associated with autoimmune or immunodeficiency conditions. It can present with respiratory symptoms and radiographic findings of interstitial lung disease 1.Diagnosis
Clinical Presentation: Recurrent pneumothoraces, bilateral interstitial and alveolar infiltrates 1.
Imaging: Chest CT showing interstitial and alveolar infiltrates 1.
Histology: Histopathologic examination revealing lymphocytic infiltration of the lung interstitium 1.
Serology: Negative HIV status in reported cases, though broader serologic screening may be warranted 1.Management
Supportive Care: Oxygen therapy, monitoring for respiratory failure 1.
Corticosteroids: First-line treatment for managing inflammation; specific dosing not detailed in abstracts 1.
Immunosuppressive Agents: Consideration in refractory cases, though specific agents and dosing are not specified 1.Special Populations
No Specific Data: Limited information on pregnancy, pediatrics, elderly, or comorbidities in the provided abstracts 1.Key Recommendations
Histologic Confirmation: Obtain lung biopsy for definitive diagnosis of lymphocytic interstitial pneumonitis (Evidence: Weak) 1.
Initiate Corticosteroids: Start corticosteroid therapy for symptomatic management (Evidence: Weak) 1.
Monitor for Recurrent Pneumothoraces: Increased vigilance in patients with history of pneumothoraces due to potential recurrence (Evidence: Expert opinion) 1.References
1 Parker JS, Shellito J, Pei LA, Mason CM. Lymphocytic interstitial pneumonitis presenting as recurrent pneumothoraces. Chest 1991. link